Financial Statements

Editas Medicine, Inc. (EDIT)

$11.68

+0.82 (+7.55%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) -665-549-416-306-
Net Income -193-116-134-110-120
Stock Dividends --1-0-186
Dividend Paid -----
Retained Earnings -858-665-549-416-306

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 39404039-
Annual Depreciation 1276642
Capital Expenditure -8-7-6-5-2
Net PPE 4339404039

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -----
New Purchases -375-459-342-458-409
Intangible and Goodwill -----

Editas Medicine, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Editas Medicine, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.